As a public health precaution due to COVID-19 (coronavirus), the 3rd Annual Arnold Aging Lecture that was to be held on April 9, 2020, is postponed. Due to the rapidly changing nature of the situation, we are not announcing a date for the lecture at this time and will provide updates on our website (https://sph.sc.edu/arnold_lecture).
The Arnold School of Public Health will host the third annual Arnold Aging Lecture on Thursday, April 9 at 3:00 p.m. The keynote presentation will be given by Dr. Maria Carrillo, the chief science officer of the national Alzheimer's Association. Dr. Carrillo’s presentation is entitled "Promising Times: Progress in Alzheimer’s Disease and Related Dementias Research." Please RSVP here by Wednesday, April 1 if you are interested in attending the lecture.
As chief science officer, Dr. Carrillo sets the strategic vision for the Alzheimer’s Association global research program. Under her leadership, the Association is the world’s largest nonprofit funder of Alzheimer’s research and an internationally recognized pioneer in convening the dementia science community to accelerate the field. As a noted public speaker, Dr. Carrillo plays an instrumental role in the Association’s efforts to lobby both the public and private sectors for increased funding for the disease.
Dr. Carrillo oversees the implementation of the Association’s research initiatives, including the Alzheimer’s Association International Conference®—the world’s largest dementia science meeting—and the Research Roundtable, which convenes scientific, industry and government leaders to overcome shared obstacles in Alzheimer’s science and drug development. In addition, Dr. Carrillo manages the World Wide Alzheimer’s Disease Neuroimaging Initiative, a multi-country research effort aimed at accelerating the early detection of Alzheimer’s.
The Association’s leadership in Alzheimer’s research continues to thrive through its International Research Grants Program, which has invested more than $455 million in innovative science since 1982. In addition, the Association has expanded its role in advancing dementia science by becoming directly involved in research. Dr. Carrillo is a co-primary investigator for the U.S. POINTER study, a lifestyle intervention trial to prevent cognitive decline and dementia.
Dr. Carrillo has published extensively on early diagnosis and biomarker standardization efforts, as well as on the global challenges to progress for research in Alzheimer’s and dementia. She is a co-author of the “Appropriate Use Criteria for Amyloid Imaging,” published by the Society of Nuclear Medicine and Molecular Imaging and the Alzheimer’s Association.
As an internationally respected Alzheimer’s expert, Dr. Carrillo has been featured in numerous media outlets, including The New York Times, The Wall Street Journal, Time magazine and “NBC Nightly News with Lester Holt.” She received the 2018 Alumnae Award from Northwestern University, recognizing an outstanding alumna who has brought honor to the university through significant contribution and national recognition in her field. Dr. Carrillo is a member of the Global Brain Health Institute’s governing board, the World Health Organization Dementia Setting Priorities & Portfolio Analysis’s advisory committee, and the American Heart Association’s research committee.
Dr. Carrillo earned her Ph.D. from Northwestern University’s Institute for Neuroscience and completed a postdoctoral fellowship focused on Alzheimer’s brain imaging and risk factors at Rush University Medical Center in Chicago.
Arnold Aging Lecture
This lecture series is sponsored by the Gerry Sue and Norman J. Arnold Institute on Aging in partnership with the Arnold School’s Office for the Study of Aging. The Institute on Aging is dedicated to both scholarly research and the promotion of evidence-based information on aging issues. The Office for the Study of Aging is home to the state’s Alzheimer’s Disease Registry, established in 1988. For more information on the Office, please visit sph.sc.edu/osa.
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. Their mission is to eliminate Alzheimer’s disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Their vision is a world without Alzheimer’s. For more information on the Association, please visit alz.org